Is It Time to Reappraise Blood Pressure Thresholds and Targets?: A Statement from the International Society of Hypertension - A Global Perspective

Hypertension

Volumn 68, Issue 2, 2016, Pages 266-268

  Weber, Michael A ^a   Poulter, Neil R ^b   Schutte, Aletta E ^c   Burrell, Louise M ^d   Horiuchi, Masatsugu ^e   Prabhakaran, Dorairaj ^f   Ramirez, Agustin J ^g   Wang, Ji Guang ^h   Schiffrin, Ernesto L ⁱ   Touyz, Rhian M ^j  

^a Downstate Health Sciences University   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NORTH WEST UNIVERSITY   (South Africa)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^g HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^h SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

ⁱ MCGILL UNIVERSITY   (Canada)

^j UNIVERSITY OF GLASGOW   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; HYPOTENSION; LIFESTYLE MODIFICATION; MEDICAL SOCIETY; META ANALYSIS (TOPIC); PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SYSTOLIC BLOOD PRESSURE; TIME TO TREATMENT; BLOOD PRESSURE; DRUG EFFECTS; STANDARDS;

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; HUMANS; HYPERTENSION;

EID: 84976349176     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.07818     Document Type: Review

References (15)

1. The SPRINT Research Group. A randomized trial of intensive versus standard blood pressure control. N Engl J Med. 2015;373:2103-2116. doi: 10.1056/NEJMoa1511939.
2. Xie X, Atkins E, Lv J, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet. 2016;387:435-443. doi: 10.1016/ S0140-6736(15)00805-3.
3. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957-967. doi: 10.1016/S0140-6736(15)01225-8.
4. Weber MA, Lackland DT. Hypertension: Cardiovascular benefits of lowering blood pressure. Nat Rev Nephrol. 2016;12:202-204. doi: 10.1038/ nrneph.2016.27.
5. Touyz RM, Dominiczak AF. Hypertension guidelines: is it time to reappraise blood pressure thresholds and targets? Hypertension. 2016;67:688-689. doi: 10.1161/HYPERTENSIONAHA.116.07090.
6. Myers MG, Kaczorowski J, Paterson JM, Dolovich L, Tu K. Thresholds for Diagnosing Hypertension Based on Automated Office Blood Pressure Measurements and Cardiovascular Risk. Hypertension. 2015;66:489-495. doi: 10.1161/HYPERTENSIONAHA.115.05782.
7. Schiffrin EL, Calhoun DA, Flack JM. SPRINT proves that lower is better for nondiabetic high-risk patients, but at a price. Am J Hypertens. 2016;29:2-4. doi: 10.1093/ajh/hpv190.
8. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels-updated overview and meta-analyses of randomized trials. J Hypertens. 2016;34:613-622. doi: 10.1097/HJH.0000000000000881.
9. Wright JT Jr, Fine LJ, Lackland DT, Ogedegbe G, Dennison Himmelfarb CR. Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view. Ann Intern Med. 2014;160:499-503. doi: 10.7326/M13-2981.
10. Lonn EM, Bosch J, López-Jaramillo P, et al; HOPE-3 Investigators. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med. 2016;374:2009-2020. doi: 10.1056/ NEJMoa1600175.
11. Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575-1585.
12. Cooper-DeHoff RM, Gong Y, Handberg EM, Bavry AA, Denardo SJ, Bakris GL, Pepine CJ. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA. 2010;304:61-68. doi: 10.1001/jama.2010.884.
13. Brunström M, Carlberg B. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. BMJ. 2016;352:i717.
14. Weber MA, Bloch M, Bakris GL, Weir MR, Zappe DH, Dahlof B, Velazquez EJ, Pitt B, Basile JN, Jamerson K, Hua TA. Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy. J Clin Hypertens (Greenwich). 2016;18:299-307. doi: 10.1111/jch.12816.
15. Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens. 2014;32:3-15. doi: 10.1097/ HJH.0000000000000065.